The epigenetic hallmarks of immune cells in cancer
Abstract Targeting the dysregulation of epigenetic mechanisms in cancer has emerged as a promising therapeutic strategy. Although the significant rationale progress of epigenetic therapies in blocking cancer cells, how epigenetic regulation shapes tumor microenvironment (TME) and establishes antitum...
Saved in:
| Main Authors: | Yu Ji, Chu Xiao, Tao Fan, Ziqin Deng, Di Wang, Wenpeng Cai, Jia Li, Tianle Liao, Chunxiang Li, Jie He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Molecular Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12943-025-02255-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SLAMF receptors: key regulators of tumor progression and emerging targets for cancer immunotherapy
by: Jia Li, et al.
Published: (2025-05-01) -
Epigenetic Regulation of Stromal and Immune Cells and Therapeutic Targets in the Tumor Microenvironment
by: Kang Liu, et al.
Published: (2025-01-01) -
Impacts of epigenetic reprogramming on innate immunity
by: Jie Fu, et al.
Published: (2024-01-01) -
Role of Epigenetics in Chronic Lung Disease
by: Felix Ritzmann, et al.
Published: (2025-02-01) -
Harnessing adjuvant-induced epigenetic modulation for enhanced immunity in vaccines and cancer therapy
by: Yasmine Megdiche, et al.
Published: (2025-02-01)